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In 11 years and 3 months, 2037 patients with HCC
were seen and 48 patients (2.4%) were diagnosed to
have obstructive icteric type HCC. Five patients
were terminally ill and were not investigated fur-
ther. Forty three patients were initially investigated
by endoscopic retrograde cholangiography (ERC) or
percutaneous transhepatic cholangiogram (PTC) and
classified as having obstructive icteric type 1, 2, or 3
HCC based on the cholangiographic findings. The
obstruction in type 1 HCC was due to intraluminal
tumour casts and/or tumour fragments obstructing
the hepatic ductal confluence or common bile duct,
while intraluminal blood clots, from haemobilia,
filling the biliary tree was the cause in type 2 HCC.
The pathology in type 3 HCC was extraluminal
obstruction by extensive tumour encasement of the
intra-hepatic biliary ductal system and/or extrinsic
compression of the hepatic and common bile ducts
by tumour(s) and/or malignant lymph nodes. At
the initial ERC/PTC, 10 patients (5 resected, 50%)
had obstructive icteric type 1 and 23 patients (0 re-
sected) had obstructive icteric type 3 HCC. Of the 10
patients initially classified according to cholangio-
graphy to have obstructive icteric type 2 HCC,
subsequent investigations revealed that 6 patients
had type 1 HCC (4 resectable,67%) and 4 patients
had type 3 HCC (0resectable). The classification of
the obstructive icteric type HCC into types 1, 2, and
3, based on the initial cholangiographic appearances
has simplified and rationalized our management
strategy for this condition.
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INTRODUCTION
Jaundice as a presenting symptom of hepato-
cellular carcinoma (HCC) occurs in 5-44% of
cases [1-4]. Its occurrence can be secondary to
parenchymal insufficiency due to the underlying
liver cirrhosis and/or parenchymal infiltration
by the HCC, to obstruction of the biliary tract
by intraluminal tumour cast/fragments/blood
clots, to extraluminal compression of the bile
ducts by the tumour or obstruction by enlarged
malignant lymph nodes at the porta hepatis. The
majority of these icteric patients has underlying
parenchymal insufficiency and a percutaneous
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ultrasound scan will demonstrate an underlying
non-dilated biliary ductal system. HCC present-
ing as obstructive jaundice is rare. The report-
ed incidence varies from 0.7-11.7% [4-9]. Lin
coined the term "icteric type" HCC for these
cases and stressed their peculiarity which can
give rise to diagnostic difficulty [8]. Despite re-
markable improvements in the diagnostic tools
available for investigating obstructive jaundice,
not infrequently, these cases are still misdiag-
nosed as cholangiocarcinoma or choledocho-
lithiasis. Prompt recognition of this type of HCC
with relief, of the obstruction either by stenting
or resection can lead to extended survival with
good palliation and occasionally cure [6, 7, 9-12].
Kuroyanagi and colleagues suggested the use of
early cholangiography in evaluating these cases
in order to determine the subsequent manage-
ment plan [13]. While Lee et al. and Wu et al.,
have described three main types of cholangio-
graphic appearances in their studies of these pati-
ents with obstructive icteric type HCC, the pro-
posed types of cholangiographic characteristics
tend to overlap and thus blur management deci-
sions [6,10]. Inour study of48 patients,we present
the cholangiographic features of obstructive
icteric type HCC on the initial cholangiogram
and based on these cholangiographic findings
we have established a management algorithm
whichwe have found to be useful in the diagnosis
and management of these patients.
MATERIALS AND METHODS
Patients
Over the period May 1984 to August 1995, 48
patients with HCC, Jaundice and dilated intrahe-
patic bile ducts on ultrasonography were seen at
the Joint Hepatoma Clinic at the Prince of Wales
Hospital, Hong Kong. All the relevant patients’
information at presentation and at subsequent
follow-up visits were recorded in a specially
designed clinical chart and subsequently entered
into a computer database. Routine laboratory
investigations included fullblood count, liverand
renal function tests, prothrombin time, activated
thromboplastin time, hepatitis B serology and
serum alpha-fetoprotein level. The diagnosis of
HCC was based on histology and/or an elevated
serum alpha-fetoprotein level of more than 500
ng/L in patients with space-occupying lesion(s)
within the liver.
Imaging
Endoscopic retrograde cholangiography (ERC)
was attempted in all patients. In those patients
where ERC was unsuccessful, percutaneous tra-
nshepatic cholangiogram (PTC) was performed.
The initial direct cholangiograms (ERC or PTC)
were reviewed by an interventional radiologist,
an endoscopist and a surgeon and the patients
were classified as having obstructive type 1, 2 or
3 HCC.
Obstructive Icteric Type 1 HCC Intraluminal
Tumour Casts and/or Tumour Fragments.
These patients had intraluminal tumour growth
along the hepatic duct and extending past the
confluence of the right and left hepatic ducts into
the common hepatic duct (CHD) causing partial
or complete biliary obstruction. The appearance
of the intraluminal tumour cast resembles that of
a cork in the neck of a bottle (Fig. 1). In some cases,
only intraluminal filling defects in the distal CBD
(with or without an associated tumour cast) were
seen. These filling defects were not unlike those
seen in choledocholithiasis. However, the edges
of these filling defects due to tumour fragments
were irregular, softer and less well-defined than
those due to stones (Fig. 2).ICTERIC TYPE HCC 301
FIGURE Obstructive icteric type HCC- intraluminal
obstruction by tumour cast. The appearance of the intraductal
tumour cast resembles that of a cork within the neck of the
bottle (arrows).
Obstructive Icteric Type 2 HCC Intraluminal
Blood Clots Filling the Biliary Tree.
The whole of the CBD and hepatic ducts
contained fluffy intraluminal filling defects due
FIGURE 2 Obstructive icteric type HCC intraluminal
obstruction by tumour cast and tumour fragments. ERC
demonstrating the presence of tumour fragments (arrows),
the main tumour (A) and the intraductal tumour cast (B).
to blood clots secondary to haemobilia, thus
obscuring the underlying lesion (Fig. 3). The
appearance of the filling defects do not look as
’solid’ as those due to tumour fragments.
Obstructive Icteric Type 3 HCC Extraluminal
Obstruction of CHD/CBD.
Tumour encasement and invasion of the hepatic
ducts produced localised strictures and proximal302 W.Y. LAU et al.
FIGURE 3 Obstructive icteric type 2 HCC intraluminal
obstruction by blood clots. The biliary tree is filled with
intraluminal blood clots.
dilation of the ductal system. In addition, diffuse
tumour involvement with stretching and dis-
placement of the intrahepatic ducts in the whole
liver were prominent features (Fig. 4). In some
patients, the main obstruction was extrinsic
compression of the CBD by enlarged lymph
nodes at the porta hepatis (Fig. 5). However, this
was also associated with an advanced liver
tumour with diffuse involment of the biliary
ductal system.
Patients with obstructive type 2 HCC had
repeat ERC/PTC performed in order to deline-
ate the exact nature of the underlying patholo-
gical lesion and to classify the patients into those
having type 1 or type 3 HCC as the blood clot
would have dispersed or moved. Those patients
who were considered potentially operable un-
derwent selective hepatic angiography (HA) and
computed tomography (CT). Patients with in-
operable HCC were palliated with endoscopic
or percutaneous stents unless they were ter-
minally ill. Those patients who have no evidence
of bilobar disease and/or extrahepatic disease
FIGURE 4 Obstructive icteric type 3 HCC extraluminal
obstruction. Tumour encasement and/or invasion of the
hepatic ducts leading to localised strictures (arrows) and
proximal dilatations.
and/or thrombosed main portal vein were
considered operable and underwent explora-
tion. After thorough exploration and no in-
tra-operative evidence of inoperability were
found, the tumour was deemed resectable and
completely excised.ICTERIC TYPE HCC 303
FIGURE 5 Obstructive icteric type 3 HCC extraluminal
obstruction. Extrinsic compression of the CBD by enlarged
porta hepatis lymph node (arrow).
RESULTS
In 11 years and 3 months, 2037 patients withHCC
presented to the Joint Hepatoma Clinic. Only 48
patients (2.4%) had obstructive icteric type HCC.
The mean age at presentation was 54 +/-12.9
years and there were 39 males and 9 females.
All 48 patients had a dilated biliary system on
ultrasound scan but only43 patients (89.6%) had a
liver tumour demonstrated on ultrasound. The
liver function test revealed a mean total bilirubin
level of 312.6 +/- 197.8 tmol/L (normal _< 15
tmol/L) and a mean alkaline phosphatase level
of 402.9 +/- 250.1 mol/L (normal _< 136 mol/
L). The hepatitis B surface antigen was present in
44 patients (91.7%). None were hepatitis C posi-
tive. Twenty six patients (54.2%) had a diagnostic
alpha fetoprotein level of over 500 ng/ml
(range in 48 patients was 3-486,000 ng/ml).
ERC was attempted in 43 patients and the com-
mon bile duct (CBD) was cannulated success-
fully in 35 patients (72.9%). PTC was performed
on the 8 patients who had failed ERC. No ERC or
PTC was attempted in 5 terminally ill patients.
After the initial ERC/PTC, 16 patients were
further investigated for operability with com-
puted tomography and hepatic angiography.
Five of the 10 patients (50%) with obstructive
icteric type I HCC were found to be operable on
subsequent investigations and the tumours were
resected with ’curative’ intent. Haemobilia in
the 10 patients with obstructive icteric type 2
HCC settled spontaneously and subsequent ERC
showed that 6 patients (60%) had obstructive
icteric type 1 HCC and obstructive icteric type 3
HCC affected the other 4. Four of these 6 pa-
tients with obstructive icteric type 1 HCC were
subsequently found to be operable. None of the
23 patients with obstructive icteric type 3 HCC
had resectable disease.
One additional patient was explored surgi-
cally but the tumour was found not to be resect-
able and surgical intubation was performed.
Twenty six patients were palliated with endo-
scopic stents and 5 with percutaneous stents.
Technical difficulties in 2 patients necessitated
the use of a combined percutaneous and endo-
scopic approach for the insertion of stents.
At five years, four of those patients treated
surgically were alive. None of these patients
treated medically with or without a stent
survived 5 years (Fig. 6).
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FIGURE 6 Survival curve of surgically treated
and medically treated() patients with obstructive icteric
type HCC.304 W.Y. LAU et al.
DISCUSSION
The pathology, clinical course and outcome of
the majority of these patients have been reported
elsewhere [14]. This study deals specifically with
the cholangiographic features found to be per-
tinent in the diagnosis and management of
obstructive icteric type HCC at our institution.
The description of 3 main types of cholangio-
graphic appearances by Lee et al., emphasised
the extrahepatic and intrahepatic appearances of
the ductal system [6]. It is obvious from their
description, that overlap of the different types
of appearances occurs within a single case, thus
giving rise to ambigious information on the
biliary tree which would affect management
planning. In contrast, we place sole emphasis on
the initial cholangiographic appearances of the
main ductal system at the hilum in guiding us on
our subsequent management. Obstructive jaun-
dice due to an underlyingHCC occurs onlywhen
the main biliary ductal system has been occluded
by an intraluminal lesion or by an extraluminal
compressive force. The former can occur in 3
ways: (1) after invading a branch of the intrahe-
patic ductal system, the tumour grows distally
towards and into the CHD and the tumour cast
obstructs biliary drainage from both liver lobes;
(2) tumour fragments having separated from the
proximal intraductal growth fall into and obstruct
the distal CBD; and (3) haemorrhage from the
tumour can partially or completely fill the biliary
tree with blood clots. Equally, tumour encase-
ment and/or extraluminal compression by an
enlarged lymph node leading to obstructive
jaundice will need to involve the main ductal
system around the porta hepatis and not just the
secondary ductal system.
Using the concept that intraluminal or extra-
luminal obstruction of the main biliary ducts
causes obstructive jaundice in these patients with
icteric typeHCC, we have devised a management
algorithm based on the initial cholangiographic
features (Fig. 7). Nine out of the 16 patients (56%)
diagnosed as having obstructive icteric type 1
Type
CT Angiography
Operable Inoperable
Resection
Obstructive icteric type HCC
ERC PTC
Type Type
Repeat ERC PTC
Palliate
Type T with
FIGURE 7 Management algorithm for obstructive icteric
type HCC based on the initial cholangiographic features.
HCC on cholangiography were found to have
resectable lesions (5 with tumour cast or "cork
sign" and 4 with tumour fragments) at subse-
quent surgical exploration. The cholangiographic
appearance of obstructive icteric type 2 HCC is
indeterminate and is a consequence of haemobi-
lia. Haemobilia secondary to haemorrhage from
HCC may partially or completely fill the entire
biliary tree with blood clots [9,15-17]. It is dif-
ficult to differentiate between haemobilia due
to HCC or to other causes on cholangiography
alone. When haemobilia is diagnosed duringERC
or PTC, it is advisable to establish biliary
drainage, allow the haemobilia to subside and
then repeat the cholangiogram to better assess the
cause of the bleeding and determine whether
it is type I or type 3 obstructive icteric type HCC.
This strategy, in managing our 10 patients
with obstructive icteric type 2 HCC, led to the
identification of 6 patients with an underlying
obstructive icteric type 1 HCC, of whom 4 un-
derwent subsequent exploration and resection.
The other 4 patients had icteric type 3 HCC. Thus,
all patients with type 1 and 2 icteric type HCC
should be investigated further and appropriate
patients should be offered surgical exploration
+/- resection.
Extraluminal obstruction of the biliary ductal
system, as seen in obstructive icteric type 3 HCC,
can be due to extrinsic compression by the un-
derlying HCC and/or enlarged lymph nodes at
the porta hepatis. In advanced HCC, tumour
encasement of the biliary system leading toICTERIC TYPE HCC 305
irregular strictures and proximal dilatations on
cholangiography are not uncommon [6,10] and
can be confused with carcinoma of the bile duct.
Differentiating obstructive icteric typeHCC from
cholangiocarcinoma can be difficult. On cholan-
giogram, bile duct carcinoma causes a "rat tail"
stricture in 70% of the cases. In 25% a bulky
tumour grows along the long axis of the duct and
in 5% polypoid lesions within the duct will give
rise to filling defects on cholangiography [18].
Although no one cholangiographic feature is
diagnostic ofHCC, the presence of the cholangio-
graphic.appearances as described here in a jaun-
diced patient with positive hepatitis B serology
and/or cirrhosis would make the diagnosis of
obstructive icteric type HCC most likely.
HCC is a rare condition in the North American
and European continents. However, it is the most
common cancer in the world and is probably the
most common malignancy in males and is re-
sponsible for 1 million deaths per year [19,20].
Obstructive icteric type HCC is rarer but prompt
intervention in the appropriate patients in the
form of palliative drainage of the obstructed sys-
tem or surgical resection can lead to prolonged
survival and potentially cure [6, 7, 9-13, 21- 25].
We have found that the classification of the
obstructive icteric type HCC into types 1, 2 and
3, based on the cholangiographic appearances
described above, has simplified and rationalized
our management strategy for this uncommon but
potentially salvagable condition.
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